MicroRNAs as the critical regulators of cisplatin resistance in gastric tumor cells.

Genes and Environment : the Official Journal of the Japanese Environmental Mutagen Society
Amir Sadra Zangouei, Meysam Moghbeli

Abstract

Combined chemotherapeutic treatment is the method of choice for advanced and metastatic gastric tumors. However, resistance to chemotherapeutic agents is one of the main challenges for the efficient gastric cancer (GC) treatment. Cisplatin (CDDP) is used as an important regimen of chemotherapy for GC which induces cytotoxicity by interfering with DNA replication in cancer cells and inducing their apoptosis. Majority of patients experience cisplatin-resistance which is correlated with tumor metastasis and relapse. Moreover, prolonged and high-dose cisplatin administrations cause serious side effects such as nephrotoxicity, ototoxicity, and anemia. Since, there is a high rate of recurrence after CDDP treatment in GC patients; it is required to clarify the molecular mechanisms associated with CDDP resistance to introduce novel therapeutic methods. There are various cell and molecular processes associated with multidrug resistance (MDR) including drug efflux, detoxification, DNA repair ability, apoptosis alteration, signaling pathways, and epithelial-mesenchymal transition (EMT). MicroRNAs are a class of endogenous non-coding RNAs involved in chemo resistance of GC cells through regulation of all of the MDR mechanisms. In present r...Continue Reading

References

Apr 29, 1998·Nature·M Baggiolini
Apr 14, 1999·Proceedings of the National Academy of Sciences of the United States of America·L C Cantley, B G Neel
Oct 20, 2001·Progress in Nucleic Acid Research and Molecular Biology·T E RocheS A Kasten
May 30, 2003·The EMBO Journal·Hiroyuki MarusawaJohn C Reed
Jan 24, 2004·Science·Abdolrahman S NateriAxel Behrens
Mar 30, 2004·Biochemical Society Transactions·T MaehamaY Kanaho
Oct 27, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Xiaoyan ZhouDihua Yu
Mar 25, 2006·Future Oncology·Haojie Huang, Donald J Tindall
Jul 11, 2006·The New England Journal of Medicine·David Cunningham MAGIC Trial Participants
Oct 25, 2006·Nature Reviews. Cancer·George A Calin, Carlo M Croce
Nov 7, 2006·Cancer Treatment Reviews·Cara A Rabik, M Eileen Dolan
Feb 22, 2007·Annual Review of Nutrition·Noboru Mizushima, Daniel J Klionsky
Oct 20, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Domagoj Vucic, Wayne J Fairbrother
Oct 26, 2007·Trends in Cell Biology·Kara L CervenyHiromi Sesaki
Jan 29, 2008·International Journal of Cancer. Journal International Du Cancer·Yoshiki MizukamiHideki Fujii
May 2, 2008·International Journal of Cancer. Journal International Du Cancer·Lin XiaDaiming Fan
Jun 19, 2008·Genes & Development·Der-Fen SuenRichard J Youle
Jul 23, 2008·Molecular Cancer Therapeutics·Olga KovalchukIgor P Pogribny
Aug 13, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Liana AdamColin Dinney
Dec 2, 2009·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Richard HummelJoerg Haier
Dec 17, 2009·Biochimica Et Biophysica Acta·Ryan J O DowlingNahum Sonenberg
Feb 12, 2010·Methods : a Companion to Methods in Enzymology·Evan M KrohMuneesh Tewari
Jul 10, 2010·Science·Miao-Chih TsaiHoward Y Chang
Jan 20, 2011·Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract·Richard HummelDamian J Hussey
Jun 8, 2011·Nature Reviews. Clinical Oncology·Maria Angelica CortezGeorge A Calin
Jul 16, 2011·Cancer Treatment Reviews·J GongM Bebawy
Aug 6, 2011·Pharmaceutical Research·Ailbhe M McDermottMichael J Kerin
Oct 7, 2011·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Haiyan ZhaiStella E Tsirka
Nov 25, 2011·BMC Medical Genomics·Chang Hee KimJeffrey E Green
Dec 14, 2011·The Journal of Biological Chemistry·Zhenyou ZouKe Zen

❮ Previous
Next ❯

Software Mentioned

CircDONSON

Related Concepts

Related Feeds

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Autophagy & Metabolism

Autophagy preserves the health of cells and tissues by replacing outdated and damaged cellular components with fresh ones. In starvation, it provides an internal source of nutrients for energy generation and, thus, survival. A powerful promoter of metabolic homeostasis at both the cellular and whole-animal level, autophagy prevents degenerative diseases. It does have a downside, however--cancer cells exploit it to survive in nutrient-poor tumors.

Autophagy & Model Organisms

Autophagy is a cellular process that allows degradation by the lysosome of cytoplasmic components such as proteins or organelles. Here is the latest research on autophagy & model organisms

Related Papers

Medical Oncology and Tumor Pharmacotherapy
G A HospersE G De Vries
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology
Ying ChenLongbang Chen
© 2021 Meta ULC. All rights reserved